Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?
Journal of Clinical Oncology · 2024
DOI: 10.1200/jco.24.00992 ↗Kurz gefasst
Leserbrief in der Zeitschrift Journal of Clinical Oncology, 2024. Verfasst von Aoba Okeya und 3 weiteren Autor:innen. Beteiligte Einrichtung: Aoba Okeya, MD, Department of Breast Surgical Oncology, National Center for Global Health and Medicine, Tokyo, Japan; Akihiko Shimomura, MD, PhD, Dep…. Hauptthemen laut MEDLINE: Breast Neoplasms, Estrogen Receptor alpha, Erb-b2 Receptor Tyrosine Kinases, Mutation. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Aoba Okeya, MD, Department of Breast Surgical Oncology, National Center for Global Health and Medicine, Tokyo, Japan; Akihiko Shimomura, MD, PhD, Department of Breast and Medical Oncology, National Center for Global Hea…
ORCID-Profile: Akihiko Shimomura, Dai Kitagawa, Chikako Shimizu
Zitieren
APA
Okeya, A., Shimomura, A., Kitagawa, D., & Shimizu, C. (2024). Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?. Journal of Clinical Oncology. https://doi.org/10.1200/jco.24.00992
Vancouver
Okeya A, Shimomura A, Kitagawa D, Shimizu C. Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?. Journal of Clinical Oncology. 2024. doi:10.1200/jco.24.00992
BibTeX
@article{Okeya2024,
author = {Okeya, Aoba and Shimomura, Akihiko and Kitagawa, Dai and Shimizu, Chikako},
title = {Are Oral Selective Estrogen Receptor Degraders Beneficial for Patients With ESR1 -Mutated Estrogen Receptor–Positive Human Epidermal Growth Factor 2–Negative Breast Cancer?},
journal = {Journal of Clinical Oncology},
year = {2024},
doi = {10.1200/jco.24.00992}
}
EUVIMED